Vimarsana
Biggest News Aggregation in the World

Page 8 - Liquidia Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liquidia Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liquidia Technologies Today - Breaking & Trending Today

Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023 - Vimarsana News

Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023

MORRISVILLE, N.C., April 27, 2023 -- Liquidia Corporation announced today that it will report its first quarter 2023 financial results on Thursday, May 4, 2023. The company will host a webcast at... | April 27, 2023

LIQUIDIA CORPORATION : LQDA Stock Price | US53635D2027 - Vimarsana News

LIQUIDIA CORPORATION : LQDA Stock Price | US53635D2027

LIQUIDIA CORPORATION (NASDAQ:LQDA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share LIQUIDIA CORPORATION | Nasdaq: LQDA | Nasdaq

Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference - Vimarsana News

Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference

MORRISVILLE, N.C., April 11, 2023 -- Liquidia Corporation announced today that Mr. Michael Kaseta, Chief Financial Officer, will provide an overview and update on the company's business during a... | April 11, 2023

Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications - Vimarsana News

Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications

New agreement supersedes the collaboration agreement entered in 2012GSK retains non-exclusive right to use PRINT for pre-clinical research for inhaled deliveryLiquidia can apply PRINT to any... | April 3, 2023

Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH) - Vimarsana News

Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)

Liquidia and Sandoz will collaborate with Mainbridge Health Partners to develop a new infusion pumpLiquidia and Sandoz have also extended the term of their promotion agreement for Treprostinil... | December 5, 2022